Advertisement

Syncope pp 153-177 | Cite as

Reflex Syncope (Neurally Mediated Syncope)

  • Michele Brignole
  • David G. Benditt
Chapter

Abstract

Reflex syncope (synonym: neurally mediated [reflex] syncope) refers to a reflex response that, when triggered, gives rise to vaso-/venodilatation and/or bradycardia; however, the contribution of each of these two factors to systemic hypotension and cerebral hypoperfusion may differ considerably among affected individuals and may even differ in the same patient at different times. Since all forms of reflex syncope share essentially the same basic pathophysiology (i.e., they basically represent the same disorder as best as we currently understand), the apparent clinical differences only reflect primarily which specific trigger elicits the reflex.

Keywords

Carotid Sinus Structural Heart Disease Prodromal Symptom Cardiac Pace Vasovagal Syncope 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Brignole M, et al. Guidelines on management (diagnosis and treatment) of syncope: Update 2004. Europace. 2004;6:467–537.PubMedCrossRefGoogle Scholar
  2. 2.
    Moya A, et al. Guidelines for the diagnosis and management of syncope (version 2009). Eur Heart J. 2009;30:2631–2671.PubMedCrossRefGoogle Scholar
  3. 3.
    Del Rosso A, et al. Relation of clinical presentation of syncope to the age of patients. Am J Cardiol. 2005;96:1431–1435.PubMedCrossRefGoogle Scholar
  4. 4.
    Alboni P, et al. Clinical spectrum of neurally-mediated reflex syncopes. Europace. 2004;6: 55–62.PubMedCrossRefGoogle Scholar
  5. 5.
    Alboni P, et al. Is vasovagal syncope a disease? Europace. 2007;9:83–87.PubMedCrossRefGoogle Scholar
  6. 6.
    Brignole M, et al. A new management of syncope: Prospective systematic guideline-based evaluation of patients referred urgently to general hospitals. Eur Heart J. 2006;27:76–82.PubMedCrossRefGoogle Scholar
  7. 7.
    Brignole M, et al. Prospective multicentre systematic guideline-based management of patients referred to the syncope units of general hospitals. Europace. 2010;12:109–118.PubMedCrossRefGoogle Scholar
  8. 8.
    Alboni P, et al. An abnormal neural reflex plays a role in causing syncope in sinus bradycardia. J Am Coll Cardiol. 1993;22:1130–1134.PubMedCrossRefGoogle Scholar
  9. 9.
    Brignole M, et al. Role of autonomic reflexes in syncope associated with paroxysmal atrial fibrillation. J Am Coll Cardiol. 1993;22:1123–1129.PubMedCrossRefGoogle Scholar
  10. 10.
    Leitch JW, et al. Syncope associated with supraventricular tachycardia: An expression of tachycardia or vasomotor response. Circulation. 1992;85:1064–1071.PubMedCrossRefGoogle Scholar
  11. 11.
    Benditt DG. Neurally mediated syncopal syndromes: pathophysiological concepts and clinical evaluation. Pacing Clin Electrophysiol. 1997;20:572–584.PubMedCrossRefGoogle Scholar
  12. 12.
    Hamer AWF, Bray JE. Clinical recognition of neurally mediated syncope. Intern Med J. 2005;35:216–221.PubMedCrossRefGoogle Scholar
  13. 13.
    Mathias CJ, et al. Observations on recurrent syncope and presyncope in 641 patients. Lancet. 2001;357:348–353.PubMedCrossRefGoogle Scholar
  14. 14.
    Ganzeboom KS, et al. Prevalence and triggers of syncope in medical students. Am J Cardiol. 2003;91:1006–1008.PubMedCrossRefGoogle Scholar
  15. 15.
    Benditt DG, et al. Effect of cough on heart rate and blood pressure in patients with “cough syncope”. Heart Rhythm. 2005;2:807–813.PubMedCrossRefGoogle Scholar
  16. 16.
    Krediet CT, et al. Sharpey-Schafer was right: evidence for systemic vasodilatation as a mechanism of hypotension in cough syncope. Europace. 2008;10:486–488.PubMedCrossRefGoogle Scholar
  17. 17.
    Omi W, et al. Swallow syncope, a case report and review of the literature. Cardiology. 2006;105:75–79.PubMedCrossRefGoogle Scholar
  18. 18.
    Kapoor WN, et al. Defecation syncope. A symptom with multiple etiologies. Arch Intern Med. 1986;146:2377–2379.PubMedCrossRefGoogle Scholar
  19. 19.
    Sakaguchi S, et al. Syncope associated with exercise, a manifestation of neurally mediated syncope. Am J Cardiol. 1995;75:476–481.PubMedCrossRefGoogle Scholar
  20. 20.
    Colivicchi F, et al. Exercise-related syncope in young competitive athletes without evidence of structural heart disease: Clinical presentation and long-term outcome. Eur Heart J. 2002;23:1125–1130.PubMedCrossRefGoogle Scholar
  21. 21.
    O‘Mara G, Lyons D. Postprandial hypotension. Clin Geriatr Med. 2002;18:307–321.PubMedCrossRefGoogle Scholar
  22. 22.
    Puisieux F, et al. Intraindividual reproducibility of postprandial hypotension. Gerontology. 2002;48:315–320.PubMedCrossRefGoogle Scholar
  23. 23.
    Sarzi Braga S, et al. Laughter-induced syncope. Lancet. 2005;366:426.PubMedCrossRefGoogle Scholar
  24. 24.
    Krediet CTP, et al. Vasovagal syncope interrupting sleep?. Heart. 2004;90:e25.PubMedCrossRefGoogle Scholar
  25. 25.
    Jardine DL, et al. Fainting in your sleep? Clin Auton Res. 2006;16:76–78.PubMedCrossRefGoogle Scholar
  26. 26.
    Thomas JE. Hyperactive carotid sinus reflex and carotid sinus syncope. Mayo Clin Proc. 1969;44:127–139.PubMedGoogle Scholar
  27. 27.
    Puggioni E, et al. Results and complications of the carotid sinus massage performed according to the “Methods of Symptoms”. Am J Cardiol. 2002;89:599–601.PubMedCrossRefGoogle Scholar
  28. 28.
    Brignole M, et al. Survival in symptomatic carotid sinus hypersensitivity. Am Heart J. 1992;123:687–692.PubMedCrossRefGoogle Scholar
  29. 29.
    Livanis EG, et al. Situational syncope: response to head-up tilt testing and follow-up: comparison with vasovagal syncope. Pacing Clin Electrophysiol. 2004;27:918–923.PubMedCrossRefGoogle Scholar
  30. 30.
    Menozzi C, et al. Follow-up of asystolic episodes in patients with cardioinhibitory, neurally mediated syncope and VVI pacemaker. Am J Cardiol. 1993;72:1152–1155.PubMedCrossRefGoogle Scholar
  31. 31.
    Maggi R, et al. Cardioinhibitory carotid sinus hypersensitivity predicts an asystolic mechanism of spontaneous neurally-mediated syncope. Europace. 2007;9:563–567.PubMedCrossRefGoogle Scholar
  32. 32.
    Brignole M, et al. Early application of an implantable loop recorder allows effective specific therapy in patients with recurrent suspected neurally mediated syncope. Eur Heart J. 2006;27:1085–1092.PubMedCrossRefGoogle Scholar
  33. 33.
    Krediet P, et al. Management of vasovagal syncope: controlling or aborting faints by leg crossing and muscle tensing. Circulation. 2002;106:1684–1689.PubMedCrossRefGoogle Scholar
  34. 34.
    Brignole M, et al. Isometric arm counter-pressure maneuvers to abort impending vasovagal syncope. J Am Coll Cardiol. 2002;40:2054–2060.CrossRefGoogle Scholar
  35. 35.
    van Dijk N, et al. Effectiveness of physical counterpressure maneuvers in preventing vasovagal syncope: the Physical Counterpressure Manoeuvres Trial (PC-Trial). J Am Coll Cardiol. 2006;48:1652–1657.PubMedCrossRefGoogle Scholar
  36. 36.
    Croci F, et al. Efficacy and feasibility of isometric arm counter-pressure manoeuvres to abort impending vasovagal syncope during real life. Europace. 2004;6:287–291.PubMedCrossRefGoogle Scholar
  37. 37.
    Reybrouck T, et al. Long-term follow-up results of tilt training therapy in patients with recurrent neurocardiogenic syncope. Pacing Clin Electrophysiol. 2002;25:1441–1446.PubMedCrossRefGoogle Scholar
  38. 38.
    Foglia-Manzillo G, et al. Efficacy of tilt training in the treatment of neurally mediated syncope. A randomized study. Europace. 2004;6:199–204.PubMedCrossRefGoogle Scholar
  39. 39.
    Kinay O, et al. Tilt training for recurrent neurocardiogenic syncope: effectiveness, patient compliance, and scheduling the frequency of training sessions. Jpn Heart J. 2004;45:833–843.PubMedCrossRefGoogle Scholar
  40. 40.
    On YK, et al. Is home orthostatic self-training effective in preventing neurocardiogenic syncope? A prospective and randomized study. Pacing Clin Electrophysiol. 2007;30:638–643.PubMedCrossRefGoogle Scholar
  41. 41.
    Duygu H, et al. The role of tilt training in preventing recurrent syncope in patients with vasovagal syncope: A prospective and randomized study. Pacing Clin Electrophysiol. 2008;31:592–596.PubMedCrossRefGoogle Scholar
  42. 42.
    Flevari P, et al. Vasovagal syncope: a prospective, randomized, crossover evaluation of the effect of propranolol, nadolol and placebo on syncope recurrence and patients’ well-being. J Am Coll Cardiol. 2002;40:499–504.PubMedCrossRefGoogle Scholar
  43. 43.
    Madrid AH, et al. Lack of efficacy of atenolol for the prevention of neurally mediated syncope in a highly symptomatic population: A prospective, double-blind, randomized and placebo-controlled study. J Am Coll Cardiol. 2001;37:554–559.PubMedCrossRefGoogle Scholar
  44. 44.
    Sheldon R, et al. Effect of beta blockers on the time to first syncope recurrence in patients after a positive isoproterenol tilt table test. Am J Cardiol. 1996;78:536–539.PubMedCrossRefGoogle Scholar
  45. 45.
    Sheldon R, et al. Prevention of syncope trial (POST): a randomized, placebo-controlled study of metoprolol in the prevention of vasovagal syncope. Circulation. 2006;113:1164–1170.PubMedCrossRefGoogle Scholar
  46. 46.
    Brignole M, et al. A controlled trial of acute and long-term medical therapy in tilt-induced neurally mediated syncope. Am J Cardiol. 1992;70:339–342.PubMedCrossRefGoogle Scholar
  47. 47.
    Moya A, et al. Limitations of head-up tilt test for evaluating the efficacy of therapeutic interventions in patients with vasovagal syncope: results of a controlled study of etilefrine versus placebo. J Am Coll Cardiol. 1995;25:65–69.PubMedCrossRefGoogle Scholar
  48. 48.
    Kaufman H, et al. Midodrine in neurally mediated syncope: a double-blind randomized cross-over study. Ann Neurol. 2002;52:342–345.CrossRefGoogle Scholar
  49. 49.
    Raviele A, et al. Effect of etilefrine in preventing syncopal recurrence in patients with vasovagal syncope: a double-blind, randomized, placebo-controlled trial. Circulation. 1999;99:1452–1457.PubMedCrossRefGoogle Scholar
  50. 50.
    Ward CR, et al. Midodrine: a role in the management of neurocardiogenic syncope. Heart. 1998;79:45–49.PubMedGoogle Scholar
  51. 51.
    Samniah N, et al. Efficacy and safety of midodrine hydrochloride in patients with refractory vasovagal syncope. Am J Cardiol. 2001;88:80–83.CrossRefGoogle Scholar
  52. 52.
    Perez-Lugones A, et al. Usefulness of midodrine in patients with severely symptomatic neurocardiogenic syncope: a randomized control study. J Cardiovasc Electrophysiol. 2001;12: 935–938.PubMedCrossRefGoogle Scholar
  53. 53.
    Salim MA, et al. Effectiveness of fludrocortisone and salt in preventing syncope recurrence in children: a double blind, placebo-controlled, randomized trial. J Am Coll Cardiol. 2005;45:484–488.PubMedCrossRefGoogle Scholar
  54. 54.
    di Girolamo E, et al. Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, on refractory vasovagal syncope: a randomized, double-blind, placebo-controlled study. J Am Coll Cardiol. 1999;33:1227–1230.PubMedCrossRefGoogle Scholar
  55. 55.
    Voss DM. Demand pacing and carotid sinus syncope. Am Heart J. 1970;79:544–547.PubMedCrossRefGoogle Scholar
  56. 56.
    Morley CA, et al. Carotid sinus syncope treated by pacing. Analysis of persistent symptoms and role of atrio ventricular sequential pacing. Br Heart J. 1982;47:411–418.PubMedCrossRefGoogle Scholar
  57. 57.
    Brignole M, et al. Long-term outcome of paced and non paced patients with severe carotid sinus syndrome. Am J Cardiol. 1992;69:1039–1043.PubMedCrossRefGoogle Scholar
  58. 58.
    Claesson JE, et al. Less syncope and milder symptoms in patients treated with pacing for induced cardioinhibitory carotid sinus syndrome: a randomized study. Europace. 2007;9: 932–936.PubMedCrossRefGoogle Scholar
  59. 59.
    Connolly SJ, et al. The North American Vasovagal Pacemaker Study (VPS). A randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope. J Am Coll Cardiol. 1999;33:16–20.PubMedCrossRefGoogle Scholar
  60. 60.
    Sutton R, et al. Dual-chamber pacing in the treatment of neurally mediated tilt-positive cardioinhibitory syncope : pacemaker versus no therapy: a multicenter randomized study. Circulation. 2000;102:294–299.PubMedCrossRefGoogle Scholar
  61. 61.
    Ammirati F, et al. Permanent cardiac pacing versus medical treatment for the prevention of recurrent vasovagal syncope: a multicenter, randomized, controlled trial. Circulation. 2001;104:52–57.PubMedCrossRefGoogle Scholar
  62. 62.
    Connolly SJ, et al. Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope: Second Vasovagal Pacemaker Study (VPS II): A randomized trial. JAMA. 2003;289:2224–2229.PubMedCrossRefGoogle Scholar
  63. 63.
    Raviele A, et al. A randomized, double-blind, placebo-controlled study of permanent cardiac pacing for the treatment of recurrent tilt-induced vasovagal syncope. The Vasovagal Syncope and Pacing Trial (SYNPACE). Eur Heart J. 2004;25:1741–1748.PubMedCrossRefGoogle Scholar
  64. 64.
    Sud S, et al. The expectation effect and cardiac pacing for refractory vasovagal syncope. Am J Med. 2007;120:54–62.PubMedCrossRefGoogle Scholar
  65. 65.
    Sud S, et al. Implications of mechanism of bradycardia on response to pacing in patients with unexplained syncope. Europace. 2007;9:312–318.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag London Limited 2011

Authors and Affiliations

  1. 1.Dipartimento di Cardiologia, Centro AritmologicoOspedali del TigullioLavagnaItaly
  2. 2.Cardiac Arrhythmia CenterMedical School, University of MinnesotaMinneapolisUSA

Personalised recommendations